AzTrials
AzTrials

Early Childhood DevelopmentNCT07418528

Understanding Early Development of Infants and Toddlers

An observational study of Early Childhood Development and Infant Development, run by Bartosz M. Radtke at 1 site in Poland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to analyze early development in infants and young children from a biopsychosocial perspective, with a particular focus on cognitive, language, motor, social-emotional, and adaptive functioning during the first years of life. Read more about this study

Who is it for?
Ages 16 days to 42 monthsHealthy volunteers can take part
What is being tested?
Psychological developmental assessment
How many people
1,200 participants
Where
1 sitePoland
Study dates
2 Jan 2025to Mar 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 days to 42 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Infants and young children aged 16 days to 42 months, including children with typical development and children with increased developmental risk.

Who may be able to join

  • Infants and young children aged from 16 days to 42 months at the time of assessment.
  • Participation of a parent or legal guardian able to provide informed consent.
  • Child's ability to participate in a standardized developmental assessment appropriate for age and developmental level.
  • Availability of basic medical and perinatal information provided by parents or caregivers.
  • Assignment to one of the predefined study cohorts based on medical history and developmental status:
  • children from the general population (control group), children with developmental delay, children with confirmed genetic conditions, children born preterm between 33 and 37 weeks of gestation, children born before 33 weeks of gestation, children with a diagnosis of cerebral palsy.

Who cannot join

  • Severe acute medical condition at the time of assessment preventing participation in the psychological evaluation.
  • Uncorrected severe sensory impairments (e.g., profound visual or hearing impairment) that preclude valid administration or interpretation of the developmental assessment.
  • Medical instability or conditions requiring immediate intensive medical care.
  • Lack of informed consent from a parent or legal guardian.
  • Inability of the parent or caregiver to provide reliable information required for questionnaire-based assessment.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Rafał Nowicki, M.A. contact

+48509805591

nowicki@pracowniatestow.pl

Poland1 site, 1 recruiting
  • Laboratory of Psychological and Educational Tests

    Gdansk, Pomeranian Voivodeship, 80-239

    Rafał Nowicki, M.A., +48509805591, nowicki@pracowniatestow.pl

    Recruiting

Other trials in Poland

About this study

Official title: Understanding Early Development: A Biopsychosocial Perspective on Infant and Toddler Functioning

The goal of this observational study is to analyze early development in infants and young children from a biopsychosocial perspective, with a particular focus on cognitive, language, motor, social-emotional, and adaptive functioning during the first years of life.

The study will include infants and young children from 16 days of age up to 42 months of age, assessed during a single diagnostic session conducted by qualified specialists. The developmental assessment will include standardized diagnostic tasks and direct observation of behavior in the form of play and natural interaction, carried out in the presence of a parent or legal guardian.

Read more

In addition, information regarding the child's everyday functioning will be collected from parents or caregivers using standardized questionnaires, including data on social-emotional competencies, communication, and adaptive skills.

The main research questions addressed by this study are:

What is the developmental profile of infants and young children in the first years of life?

What relationships exist between different domains of early development within a biopsychosocial model of child functioning?

Can specific developmental patterns be identified that indicate an increased risk of developmental difficulties in early childhood?

How does age differentiate the structure and variability of developmental functioning across assessed domains?

The study is non-invasive and observational in nature. Data will be analyzed exclusively in aggregated form and will contribute to a better understanding of early child development as well as to the development of norms and tools supporting early diagnosis and developmental intervention.

Being tested
Psychological developmental assessment
Keywords
Early development, Infant development, Toddler development, Neurodevelopment, Cognitive development, Language development, Motor development, Social-emotional development, Adaptive behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Psychological developmental assessmentDiagnostic test

    All participants undergo a standardized psychological developmental assessment conducted by trained specialists. The assessment includes structured diagnostic tasks and direct observation of the child's behavior during play and natural interaction, carried out in the presence of a parent or legal guardian. In addition, parents or caregivers complete standardized questionnaires assessing the child's social-emotional functioning and adaptive behavior. No experimental intervention or therapeutic procedure is applied.

Study groups in NCT07418528
Study groupRoleWhat they receive
Control GroupChildren without identified developmental delays, genetic conditions, or major perinatal complications, assessed as part of the general population.
Receives: Diagnostic Test: Psychological developmental assessment
Developmental DelayChildren with identified developmental delay based on prior clinical assessment or referral information, without a confirmed specific genetic diagnosis.
Receives: Diagnostic Test: Psychological developmental assessment
Genetic ConditionsChildren with confirmed genetic conditions associated with developmental risk, based on medical documentation provided by parents or caregivers.
Receives: Diagnostic Test: Psychological developmental assessment
Moderate to Late PretermChildren born preterm between 33 and 37 weeks of gestational age. This group includes infants and toddlers with a history of moderate to late prematurity, without severe neonatal complications requiring classification as extremely preterm.
Receives: Diagnostic Test: Psychological developmental assessment
Extremely PretermChildren born before 33 weeks of gestational age. This group includes infants and toddlers with a history of extreme prematurity, associated with increased risk for developmental difficulties across multiple domains.
Receives: Diagnostic Test: Psychological developmental assessment
Cerebral PalsyChildren with a diagnosis of cerebral palsy documented in medical records. This group includes children with motor impairment of neurological origin, potentially accompanied by cognitive, language, or adaptive difficulties.
Receives: Diagnostic Test: Psychological developmental assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cognitive development

    Cognitive functioning assessed using the Cognitive Scale of the Bayley Scales of Infant and Toddler Development, Fourth Edition (Bayley-4). The scale evaluates early cognitive abilities, including sensory-motor processing, exploration and manipulation, object relations, memory, problem solving, and early executive functioning. Data will be reported as a Composite Score ranging from 40 to 160, where higher scores indicate better cognitive development.

    Measured: Baseline

  2. Language Development

    Language functioning assessed using the Language Scale of the Bayley Scales of Infant and Toddler Development, Fourth Edition (Bayley-4), including receptive and expressive communication abilities appropriate to the child's developmental level. Data will be reported as a Composite Score ranging from 40 to 160, where higher scores indicate better language development.

    Measured: Baseline

  3. Motor Development

    Motor functioning assessed using the Motor Scale of the Bayley Scales of Infant and Toddler Development, Fourth Edition (Bayley-4), including fine and gross motor skills related to coordination, posture, locomotion, and motor planning. Data will be reported as a Composite Score ranging from 40 to 160, where higher scores indicate better motor development.

    Measured: Baseline

Secondary outcomes (2)
  1. Social-emotional functioning

    Social-emotional development assessed using the Social-Emotional Scale of the Bayley Scales of Infant and Toddler Development, Fourth Edition (Bayley-4), based on parent-reported information regarding emotional regulation, social engagement, communication of needs, and relationship development. Data will be reported as a Scaled Score ranging from 1 to 19, where higher scores indicate better performance.

    Measured: Baseline

  2. Adaptive behavior functioning

    Adaptive behavior assessed using the Adaptive Behavior Scale of the Bayley Scales of Infant and Toddler Development, Fourth Edition (Bayley-4), based on parent or caregiver report of the child's everyday functional skills in communication, daily living skills, and socialization. Data will be reported as a Scaled Score ranging from 1 to 19, where higher scores indicate better performance.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Feb 2026
  2. Study start2 Jan 2025
  3. Primary completionNov 2026 (estimated)
  4. Study completionMar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
1,200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07418528
Sponsor's protocol ID
2026/PTPiP/1
Status last verified
Feb 2026
First submitted
11 Feb 2026
Last updated
23 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Early Childhood Development and Infant Development, run by Bartosz M. Radtke at 1 site in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Rafał Nowicki, M.A. (+48509805591, nowicki@pracowniatestow.pl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cognitive development (time frame: Baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in